Nath Bio Genes India Limited Stock Price Today (NSE: NATHBIOGEN)
Fundamental Score
Nath Bio Genes India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nath Bio Genes India Limited share price today is ₹129.02, down 6.22% on NSE/BSE as of 30 March 2026. Nath Bio Genes India Limited (NATHBIOGEN) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹299.59 (Cr). The 52-week high for NATHBIOGEN share price is ₹238.69 and the 52-week low is ₹126.35. At a P/E ratio of 7.25x, NATHBIOGEN is currently trading below its industry average P/E of 21.07x. The company has a Return on Equity (ROE) of 6.23% and a debt-to-equity ratio of 0.23.
Nath Bio Genes India Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Nath Bio Genes India Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Nath Bio Genes Share Price Financial Analysis
The Other Agricultural Products sector is experiencing increased volatility due to fluctuating commodity prices and unpredictable weather patterns, placing a premium on companies with robust risk management strategies. Our financial analysis examines Nath Bio Genes share price, currently at ₹152.33, through the lens of its financial stability and competitive positioning. This analysis is based on publicly available information and forms part of a larger 80-parameter fundamental audit verified by Sweta Mishra.
A key metric for evaluating Nath Bio Genes is its Price-to-Earnings (PE) ratio, which stands at 7.25. This suggests that the market is currently valuing the company at 7.25 times its earnings per share. This PE ratio invites further comparison with sector peers such as
Kaveri Seed Company Limited. While a lower PE can be attractive, a comprehensive assessment requires evaluating factors like growth potential, debt levels, and management quality. One might contrast the capital allocation acumen driving the operations and future strategies of Kaveri Seed Company Limited with what appears to be a more incrementalist approach visible at Nath Bio Genes. Management effectiveness plays a pivotal role in navigating sector challenges and maximizing shareholder value.Return on Capital Employed (ROCE), another crucial indicator, is at 6.96% for Nath Bio Genes. ROCE measures how efficiently a company uses its capital to generate profits. A ROCE of 6.96% indicates the profitability of each rupee invested in the business. The impact of this ROCE on the company's "moat," or competitive advantage, is significant. A higher ROCE typically translates to a stronger moat as the company is better positioned to reinvest profits, innovate, and withstand competitive pressures. A ROCE below sector averages might suggest a weaker competitive advantage and increased vulnerability to market fluctuations.
In conclusion, while Nath Bio Genes share price and associated metrics such as PE and ROCE offer a snapshot of the company's financial health, it is crucial to analyze these figures in the context of the broader industry landscape, peer performance, and underlying business fundamentals. Further investigation into factors such as debt levels, cash flow, and future growth prospects is necessary to form a more complete picture of the company's overall financial stability.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nath Bio Genes India Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NATHBIOGEN across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 7.25 vs Industry: 21.07)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (126.13%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (36.22%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.23)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Risk Factors
3 factors identified
Below-Average Return on Equity (6.23%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.96%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Institutional Interest (FII+DII: 1.08%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Nath Bio Genes India Limited Financial Statements
Comprehensive financial data for Nath Bio Genes India Limited including income statement, balance sheet and cash flow
About NATHBIOGEN (Nath Bio Genes India Limited)
Nath Bio-Genes India Limited is a pioneering force in the realm of Indian agricultural innovation, focusing on developing and distributing cutting-edge solutions for enhancing crop... yields and promoting sustainable farming practices. The company is dedicated to researching, producing, and marketing a diverse portfolio of high-quality agricultural products beyond conventional seeds. These include bio-stimulants, soil conditioners, and crop protection agents, all designed to work synergistically with traditional farming methods to improve plant health and resilience. NATHBIOGEN aims to empower farmers with the tools and knowledge they need to maximize productivity while minimizing their environmental footprint, fostering a future where agriculture is both efficient and environmentally responsible. Beyond seeds, NATHBIOGEN is invested in the development of advanced agricultural technologies aimed at optimizing resource utilization and reducing crop losses. This includes precision farming solutions like drone-based crop monitoring and data-driven irrigation management systems. By leveraging the power of technology, NATHBIOGEN seeks to provide farmers with real-time insights into crop health, enabling them to make informed decisions about planting, fertilization, and pest control. This proactive approach to agriculture not only boosts crop yields but also minimizes the use of water, fertilizers, and pesticides, contributing to a more sustainable and environmentally friendly farming ecosystem. The company understands agriculture's ever-evolving landscape, and is actively exploring sustainable and regenerative agriculture practices to protect farmland. At the heart of NATHBIOGEN's operations is a deep commitment to farmer education and support. The company recognizes that simply providing innovative products is not enough; farmers need to understand how to effectively use these tools to achieve optimal results. To this end, NATHBIOGEN invests heavily in training programs, field demonstrations, and advisory services, ensuring that farmers have access to the knowledge and expertise they need to succeed. By building strong relationships with farmers and providing ongoing support, NATHBIOGEN aims to create a collaborative ecosystem where innovation and practical knowledge converge to drive sustainable agricultural growth and improve the livelihoods of farming communities across India and beyond.
Company Details
Key Leadership
Corporate Events
NATHBIOGEN Share Price: Frequently Asked Questions
What is the current share price of Nath Bio Genes India Limited (NATHBIOGEN)?
As of 30 Mar 2026, 12:05 pm IST, Nath Bio Genes India Limited share price is ₹129.02. The NATHBIOGEN stock has a market capitalisation of ₹299.59 (Cr) on NSE/BSE.
Is NATHBIOGEN share price Overvalued or Undervalued?
NATHBIOGEN share price is currently trading at a P/E ratio of 7.25x, compared to the industry average of 21.07x. Based on this relative valuation, the Nath Bio Genes India Limited stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of NATHBIOGEN share price?
The 52-week high of NATHBIOGEN share price is ₹238.69 and the 52-week low is ₹126.35. These values are updated daily from NSE/BSE price data.
What factors affect the Nath Bio Genes India Limited share price?
Key factors influencing NATHBIOGEN share price include quarterly earnings growth (Sales Growth: 36.22%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Nath Bio Genes India Limited a good stock for long-term investment?
Nath Bio Genes India Limited shows a 5-year Profit Growth of N/A% and an ROE of 6.23%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.23 before investing in NATHBIOGEN shares.
How does Nath Bio Genes India Limited compare with its industry peers?
Nath Bio Genes India Limited competes with major peers in the Other Agricultural Products. Investors should compare NATHBIOGEN share price P/E of 7.25x and ROE of 6.23% against the industry averages to determine competitive standing.
What is the P/E ratio of NATHBIOGEN and what does it mean?
NATHBIOGEN share price has a P/E ratio of 7.25x compared to the industry average of 21.07x. Investors pay ₹7 for every ₹1 of annual earnings.
How is NATHBIOGEN performing according to Bull Run's analysis?
NATHBIOGEN has a Bull Run fundamental score of 27.2/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does NATHBIOGEN belong to?
NATHBIOGEN operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Nath Bio Genes India Limited share price.
What is Return on Equity (ROE) and why is it important for NATHBIOGEN?
NATHBIOGEN has an ROE of 6.23%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Nath Bio Genes India Limited generates profits from shareholders capital.
How is NATHBIOGEN debt-to-equity ratio and what does it indicate?
NATHBIOGEN has a debt-to-equity ratio of 0.23, which indicates conservative financing with low financial risk.
What is NATHBIOGEN dividend yield and is it a good dividend stock?
NATHBIOGEN offers a dividend yield of 1.27%, meaning you receive ₹1.27 annual dividend for every ₹100 invested in Nath Bio Genes India Limited shares.
How has NATHBIOGEN share price grown over the past 5 years?
NATHBIOGEN has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in NATHBIOGEN and why does it matter?
Promoters hold 45.59% of NATHBIOGEN shares, with 13.78% pledged. High promoter holding often indicates strong management confidence in Nath Bio Genes India Limited.
What is NATHBIOGEN market capitalisation category?
NATHBIOGEN has a market capitalisation of ₹300 crores, placing it in the Small-cap category.
How volatile is NATHBIOGEN stock?
NATHBIOGEN has a beta of N/A. A beta > 1 suggests the Nath Bio Genes India Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is NATHBIOGEN operating profit margin trend?
NATHBIOGEN has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is NATHBIOGEN quarterly performance?
Recent quarterly performance shows Nath Bio Genes India Limited YoY Sales Growth of 36.22% and YoY Profit Growth of 126.13%.
What is the institutional holding pattern in NATHBIOGEN?
NATHBIOGEN has FII holding of 0.32% and DII holding of 0.76%. Significant institutional holding often suggests professional confidence in the Nath Bio Genes India Limited stock.